Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproterone acetate in benign prostatic hypertrophy
IRCT20181106041572N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cyproterone in benign prostatic hyperplasia (BPH), sponsored by Mashhad University of Medical Sciences. Started Apr 2019; status: completed.
02
Drugs
cyproterone
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on IRCT20181106041572N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181106041572N1.